More Results

    Are you sure you want to change languages?

    The page you are visiting uses a different locale than your saved profile. Do you want to change your locale?

    From Sectors and Smart Beta to Fixed Income, SPDR Exchange Traded Funds (ETFs) give you wide access to diverse investment opportunities. Find out more.

    Okay

    SPDR® MSCI World Health Care UCITS ETF WHEA NA

    Important Risk Disclosure

    Equity securities may fluctuate in value in response to the activities of individual companies and general market and economic conditions.

    ETFs trade like stocks, are subject to investment risk, fluctuate in market value and may trade at prices above or below the ETFs net asset value. Brokerage commissions and ETF expenses will reduce returns.

    Investing in foreign domiciled securities may involve risk of capital loss from unfavorable fluctuation in currency values, withholding taxes, from differences in generally accepted accounting principles or from economic or political instability in other nations.

    NAV USD (Official NAV)

    $48,93

    as of 26 Feb 2021

    Base Fund Currency

    USD

    1 Day Nav Change

    -$0,58 (-1,17%)

    as of 26 Feb 2021

    Assets Under Management

    $307,95 M

    as of 26 Feb 2021

    TER

    0,30%

    image load fail

    as of 31 Jan 2021

    Quick Links

    Fund Objective

    Fund Objective

    The investment objective of the Fund is to track the performance of companies in the Health Care sector, across developed markets globally.

    Index Description

    Index Description

    The MSCI World Health Care 35/20 Capped Index measures the performance of global equities that are classified as falling within the health care sector, as per the Global Industry Classification Standard (GICS).

    Fund Information as of 26 Feb 2021

    Fund Information as of 26 Feb 2021
    ISIN iNAV Ticker

    *These ticker codes are representative of the primary listing exchange.

    		 Inception Date Countries of Registration Base Fund Currency Income Treatment Settlement Cycle
    IE00BYTRRB94 INWHEAE 29 Apr 2016 Austria, Denmark, Finland, France, Germany, Ireland, Italy, Luxembourg, Netherlands, Norway, Spain, Sweden, Switzerland, United Kingdom USD Accumulation Redemption Settlement Cycle, DD+3; Subscription Settlement Cycle, DD+3
    ISIN IE00BYTRRB94
    iNAV Ticker

    *These ticker codes are representative of the primary listing exchange.

    		 INWHEAE
    Inception Date 29 Apr 2016
    Countries of Registration Austria, Denmark, Finland, France, Germany, Ireland, Italy, Luxembourg, Netherlands, Norway, Spain, Sweden, Switzerland, United Kingdom
    Base Fund Currency USD
    Income Treatment Accumulation
    Settlement Cycle Redemption Settlement Cycle, DD+3; Subscription Settlement Cycle, DD+3
    Trading Cycle TER Benchmark Minimum Investment Trading Currency UCITS Compliant Domicile
    DD+1 0,30% MSCI World Health Care 35/20 Capped Index 1 Share EUR, USD Yes Ireland
    Trading Cycle DD+1
    TER 0,30%
    Benchmark MSCI World Health Care 35/20 Capped Index
    Minimum Investment 1 Share
    Trading Currency EUR, USD
    UCITS Compliant Yes
    Domicile Ireland
    Investment Manager Sub-Investment Manager Fund Umbrella Replication Method Distribution Frequency PEA Eligible ISA Eligible
    State Street Global Advisors Limited State Street Global Advisors GmbH (Poland Branch) SSGA SPDR ETFs Europe II plc Replicated - No Yes
    Investment Manager State Street Global Advisors Limited
    Sub-Investment Manager State Street Global Advisors GmbH (Poland Branch)
    Fund Umbrella SSGA SPDR ETFs Europe II plc
    Replication Method Replicated
    Distribution Frequency -
    PEA Eligible No
    ISA Eligible Yes
    SIPP Eligible UK Reporting Status Securities Lending
    Yes Yes Yes
    SIPP Eligible Yes
    UK Reporting Status Yes
    Securities Lending Yes

    Listing and Ticker Information as of 26 Feb 2021

    Listing and Ticker Information as of 26 Feb 2021

    Exchange Euronext Amsterdam (Primary)
    Trading Currency EUR
    Listing Date 03 May 2016
    Exchange Ticker WHEA
    SEDOL Code BYZJ0B0
    Bloomberg Code WHEA NA
    Reuters Code WHEA.AS
    Exchange London Stock Exchange
    Trading Currency USD
    Listing Date 04 May 2016
    Exchange Ticker WHEA
    SEDOL Code BYYW128
    Bloomberg Code WHEA LN
    Reuters Code WHEA.L
    Exchange SIX Swiss Exchange
    Trading Currency USD
    Listing Date 06 May 2016
    Exchange Ticker WHEA
    SEDOL Code BYZJ0N2
    Bloomberg Code WHEA SE
    Reuters Code WHEA.S
    Exchange Borsa Italiana
    Trading Currency EUR
    Listing Date 30 Jan 2019
    Exchange Ticker WHEA
    SEDOL Code BHXH6F3
    Bloomberg Code WHEA IM
    Reuters Code WHEA.MI
    Exchange Trading Currency Listing Date Exchange Ticker SEDOL Code Bloomberg Code Reuters Code
    Euronext Amsterdam (Primary) EUR 03 May 2016 WHEA BYZJ0B0 WHEA NA WHEA.AS
    London Stock Exchange USD 04 May 2016 WHEA BYYW128 WHEA LN WHEA.L
    SIX Swiss Exchange USD 06 May 2016 WHEA BYZJ0N2 WHEA SE WHEA.S
    Borsa Italiana EUR 30 Jan 2019 WHEA BHXH6F3 WHEA IM WHEA.MI

    INAV

    INAV

    Estimated NAV per Unit at 4PM, Hong Kong as of Estimated NAV per Unit as of (Updated every 15 seconds)
    As of (Updated every 15 seconds)
    INAV TICKER CURRENCY INAV
    Estimated NAV per Unit at 4PM, Hong Kong as of
    Estimated NAV per Unit as of (Updated every 15 seconds)
    As of (Updated every 15 seconds)
    INAV TICKER
    CURRENCY
    INAV

    The Indicative NAV per share should not be viewed as the actual NAV per share. The Indicative NAV per share is provided for reference purposes only and may differ from the actual NAV per share calculated in accordance with the Prospectus.

    Fund Characteristics as of 25 Feb 2021

    Fund Characteristics as of 25 Feb 2021
    Average Market Cap (M) Number of Holdings Average Price/Book Price/Earnings Ratio FY1
    $130 436,98 M 158 4,34 17,12
    Average Market Cap (M) $130 436,98 M
    Number of Holdings 158
    Average Price/Book 4,34
    Price/Earnings Ratio FY1 17,12

    Index Characteristics as of 25 Feb 2021

    Index Characteristics as of 25 Feb 2021
    Index Dividend Yield

    This measures the weighted average of gross dividend Yield of stocks, in the index.
    1,74%
    Index Dividend Yield

    This measures the weighted average of gross dividend Yield of stocks, in the index.

    		 1,74%

    Fund Market Price as of 26 Feb 2021

    Fund Market Price as of 26 Feb 2021
    Bid Price Offer Price Closing Price Bid/Offer Spread Day High Day Low 52 Week High
    €40,25 €41,00 €40,54 €0,75 €40,90 €40,33 €42,98
    Bid Price €40,25
    Offer Price €41,00
    Closing Price €40,54
    Bid/Offer Spread €0,75
    Day High €40,90
    Day Low €40,33
    52 Week High €42,98
    52 Week Low
    €30,64
    52 Week Low €30,64

    Fund Net Asset Value as of 26 Feb 2021

    Fund Net Asset Value as of 26 Feb 2021
    NAV USD (Official NAV) NAV EUR Assets Under Management Shares in Issue
    $48,93 €40,31 $307,95 M 6 293 348
    NAV USD (Official NAV) $48,93
    NAV EUR €40,31
    Assets Under Management $307,95 M
    Shares in Issue 6 293 348
    Most Recent NAV/NAV History

    Fund Performance

    Fund Performance

    • Fund Inception Date: 29 Apr 2016
    • Index Inception Date: 07 May 2020
    • Performance Inception Date: 28 Feb 2009
    Cumulative Annualised Calendar
    Month End

    as of 31 Jan 2021

    As Of 1 Month 3 Month YTD 1 Year 3 Year 5 Year Since Inception
    28 Feb 2009
    Fund Net 31 Jan 2021 1,05% 13,46% 1,05% 16,11% 36,99% 74,99% 401,54%
    Difference 31 Jan 2021 -0,02% -0,05% -0,02% -0,28% -0,26% -0,66% -11,18%
    Fund Gross 31 Jan 2021 1,07% 13,55% 1,07% 16,45% 38,23% 77,68% 422,59%
    Difference 31 Jan 2021 0,01% 0,04% 0,01% 0,07% 0,97% 2,02% 9,87%
    Index
    MSCI World Health Care 35/20 Capped Index
    		 31 Jan 2021 1,06% 13,51% 1,06% 16,38% 37,26% 75,66% 412,71%
    Month End

    as of 31 Jan 2021

    As Of 1 Month 3 Month YTD 1 Year 3 Year 5 Year Since Inception
    28 Feb 2009
    Fund Net 31 Jan 2021 1,05% 13,46% 1,05% 16,11% 11,06% 11,84% 14,48%
    Difference 31 Jan 2021 -0,02% -0,05% -0,02% -0,28% -0,07% -0,08% -0,21%
    Fund Gross 31 Jan 2021 1,07% 13,55% 1,07% 16,45% 11,39% 12,18% 14,88%
    Difference 31 Jan 2021 0,01% 0,04% 0,01% 0,07% 0,26% 0,26% 0,18%
    Index
    MSCI World Health Care 35/20 Capped Index
    		 31 Jan 2021 1,06% 13,51% 1,06% 16,38% 11,13% 11,92% 14,69%

    as of 31 Jan 2021

    2021 (YTD) 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011
    Fund Net 1,05% 13,26% 23,34% 2,48% 19,69% -6,89% 6,17% 17,71% 35,58% 17,08% 9,14%
    Difference -0,02% -0,26% 0,09% -0,04% -0,11% -0,08% -0,43% -0,39% -0,69% -0,45% -0,31%
    Fund Gross 1,07% 13,60% 23,70% 2,78% 20,05% -6,58% 6,58% 18,15% 36,08% 17,52% 9,55%
    Difference 0,01% 0,08% 0,46% 0,27% 0,25% 0,23% -0,02% 0,05% -0,18% -0,01% 0,10%
    Index
    MSCI World Health Care 35/20 Capped Index
    		 1,06% 13,52% 23,24% 2,51% 19,80% -6,81% 6,60% 18,10% 36,27% 17,54% 9,46%

    Performance Gross and Net of All Fees.

    Capital Risk: Investing involves risk including the risk of loss of capital.

    Past performance is not a guarantee of future results.

    Past performance is not an indicator of future performance. The Gross of fees do not reflect and net of fees do reflect commissions and costs incurred on the issue and redemption, or purchases and sale, of units. If the performance is calculated on the basis of Gross/net asset values that are not denominated in the accounting currency of the collective investment scheme, its value may rise or fall as a result of currency fluctuations.

    Calendar year inception performance returns will be partial for the year where the inception date for either the Fund in question or the historic performance-linked Fund (whichever is the earliest) falls within that period.

    Deviation & Tracking Error as of 31 Jan 2021

    Deviation & Tracking Error as of 31 Jan 2021

    Standard Deviation Tracking Error
    15,09% 0,10%
    Standard Deviation 15,09%
    Tracking Error 0,10%

    This calculation is based on the past 3 years performance information.

    Top Holdings

    Top Holdings
    Fund Top Holdingsas of 25 Feb 2021

    Fund Top Holdings as of 25 Feb 2021

    Security Name Weight
    Johnson & Johnson 6,47%
    UnitedHealth Group Incorporated 4,74%
    Roche Holding Ltd 3,49%
    Abbott Laboratories 3,27%
    Novartis AG 2,95%
    AbbVie Inc. 2,89%
    Pfizer Inc. 2,86%
    Merck & Co. Inc. 2,85%
    Thermo Fisher Scientific Inc. 2,70%
    Eli Lilly and Company 2,66%
    Download All Holdings: Download Daily Holdings

    Industry Allocation

    Industry Allocation
    Fund Industry Allocationas of 25 Feb 2021

    Fund Industry Allocation as of 25 Feb 2021

    Sector Weight
    Pharmaceuticals 38,78%
    Health Care Equipment & Supplies 24,74%
    Health Care Providers & Services 13,81%
    Biotechnology 13,32%
    Life Sciences Tools & Services 7,57%
    Health Care Technology 1,78%

    Geographical Weights

    Geographical Weights
    Fund Documents
    Information & Schedules
    Tax Documents

    Fund Footnote

    Characteristics, holdings and sectors shown are as of the date indicated and are subject to change. This information should not be considered a recommendation to invest in a particular sector or to buy or sell any security shown. It is not known whether the sectors or securities shown will be profitable in the future. The holdings are taken from the accounting records of SSGA which may differ from the official books and records of the custodian.

    Performance Gross and Net of All Fees.

    Capital Risk: Investing involves risk including the risk of loss of capital.

    Past performance is not a guarantee of future results.

    Past performance is not an indicator of future performance. The Gross of fees do not reflect and net of fees do reflect commissions and costs incurred on the issue and redemption, or purchases and sale, of units. If the performance is calculated on the basis of Gross/net asset values that are not denominated in the accounting currency of the collective investment scheme, its value may rise or fall as a result of currency fluctuations.

    First net asset value taken into account corresponds to the first end of month following complete investment of the portfolio in agreement with the policy of management. Historical performance is not necessarily indicative of actual future investment performance.

    The financial products referred to herein are not sponsored, endorsed, or promoted by MSCI and MSCI bears no liability with respect to any such financial products or any index on which such financial products are based. The Prospectus contains a more detailed description of the limited relationship MSCI has with SSgA and any related financial products.

    Previous to 1 December 2020, this Fund's Benchmark was the MSCI World Health Care Index.

    © 2021 Morningstar, Inc. All rights reserved. The information contained herein; (1) is proprietary to Morningstar and/or its content providers; (2) may not be copied or distributed; and (3) is not warranted to be accurate, complete or timely. Neither Morningstar nor its content providers are responsible for any damages or losses arising from any use of this information. State Street does not review the Morningstar data.

    Disclaimer: The Goldener Bulle award given by Finanzen.net on 02 February 2018 which recognises from investors who demonstrate our highest rated ETF range of all ETF companies. The award/ranking given is chosen based on investor's feedback for the time period of 01.01.2017 - 31.12.2017.

     

    Important Risk Information:

     

    SPDR ETF is the exchange traded funds ("ETF") platform of State Street Global Advisors and is comprised of funds that have been authorised by European regulatory authorities as open-ended UCITS investment companies. SPDR ETFs may not be available or suitable for you.

     

    ETFs trade like stocks, are subject to investment risk, fluctuate in market value and may trade at prices above or below the ETFs net asset value. Brokerage commissions and ETF expenses will reduce returns.

     

    Changes in exchange rates may have an adverse effect on the value, price or income of an investment. Further, there is no guarantee an ETF will achieve its investment objective.

     

    SHARES IN THE FUNDS OF THE SPDR® ETF SICAV, SSGA SPDR ETFS EUROPE I AND SSGA SPDR ETFS EUROPE II PLC MAY NOT BE AVAILABLE FOR OR SUITABLE FOR YOU. THE VIEWS EXPRESSED IN THIS SITE DO NOT CONSTITUTE INVESTMENT ADVICE. INDEPENDENT ADVICE SHOULD BE SOUGHT IN CASES OF DOUBT. NEITHER THE INFORMATION NOR ANY OPINION CONTAINED ON THIS SITE CONSTITUTES A SOLICITATION OR OFFER TO BUY OR SELL SHARES OF THE FUNDS OR ANY OTHER FINANCIAL INSTRUMENT.

     

    Standard & Poor's®, S&P® and SPDR® are registered trademarks of Standard & Poor's Financial Services LLC (S&P); Dow Jones is a registered trademark of Dow Jones Trademark Holdings LLC (Dow Jones); and these trademarks have been licensed for use by S&P Dow Jones Indices LLC (SPDJI) and sublicensed for certain purposes by State Street Corporation. State Street Corporation's financial products are not sponsored, endorsed, sold or promoted by SPDJI, Dow Jones, S&P, their respective affiliates and third party licensors and none of such parties make any representation regarding the advisability of investing in such product(s) nor do they have any liability in relation thereto, including for any errors, omissions, or interruptions of any index.

     

    SPDR ETFs may be offered and sold only in those jurisdictions where authorised, in compliance with applicable regulations.

     

    Information related to Mexico

     

    This information does not constitute and is not intended to constitute marketing or an offer of securities and accordingly should not be construed as such. The Funds referenced herein have not been, and will not be, registered under the Mexican Securities Market Law (Ley del Mercado de Valores) and may not be publicly offered or sold in the United Mexican States. Disclosure documentation related to any of the aforementioned Funds may not be distributed publicly in Mexico and shares of the Funds may not be traded in Mexico.

     

    You should obtain and read a prospectus and KIID relating to the SPDR ETFs prior to investing. Further information and the prospectus/KIID describing the characteristics, costs and risks of SPDR ETFs are available for residents of countries where SPDR ETFs are authorised for sale on the SPDRs website and from your local SSGA office.

    © 2021 %%State Street Corporation%%. All rights reserved.